Announce Date | 07/22/2025 |
EPS Normalized Actual | $7.11 (Beat by $0.19) |
EPS GAAP Actual | $7.11 (Beat by $0.19) |
Revenue Actual | $10.351B |
Revenue Surprise | Beat by $10351M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $6.63801 |
EPS GAAP Estimate | $6.63801 |
Revenue Estimate | $10.537323919B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 37.32 | 15.38 | 36.82749 | 37.77758 | 5 |
Dec 2028 | 34.425 | 16.67 | 34.00548 | 35.01703 | 8 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 8.17 | 1.505 | 10.351B | 1.28% | -180.74M |
FQ1 2025 (Mar 2025) | 3.33 | 3.33 | 9.468B | -7.02% | 9468M |
FQ4 2024 (Dec 2024) | 8.66 | 8.66 | 10.686B | 0.45% | 10686M |
FQ3 2024 (Sep 2024) | 6.96 | 6.96 | 9.996B | 2.21% | 9996M |
FQ2 2024 (Jun 2024) | 6.37 | 6.37 | 10.218B | 6.28% | 10218M |
FQ1 2024 (Mar 2024) | 6.34 | 6.34 | 10.133B | 8.21% | 10133M |
FQ4 2023 (Dec 2023) | 0 | 0 | 10.638B | 5.69% | 10638M |
FQ3 2023 (Sep 2023) | 6.2 | 6.2 | 9.775B | 8.23% | 9775M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
6.63801
Consensus Revenue Estimates
10.537323919B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 8.74573 | -- | 8.32671 | 8.95665 | 15 |
FQ3 2027 (Sep 2027) | 8.09818 | -- | 7.95992 | 8.28149 | 4 |
FQ2 2027 (Jun 2027) | 7.75377 | -- | 7.62139 | 7.92929 | 3 |
FQ1 2027 (Mar 2027) | 7.47718 | -- | 7.34952 | 7.64644 | 7 |
FQ4 2026 (Oct 2026) | 7.30602 | -- | 7.20686 | 7.41671 | 9 |
FQ3 2026 (Jul 2026) | 7.08006 | -- | 6.98397 | 7.18732 | 9 |
FQ2 2026 (Jun 2026) | 7.18923 | -13.64 | 7.08839 | 7.34699 | 9 |
FQ1 2026 (Mar 2026) | 6.91421 | 51.84 | 6.81722 | 7.06593 | 9 |
FQ4 2025 (Oct 2025) | 6.86515 | -26.14 | 6.77197 | 6.96916 | 6 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 12.9B | -- | 12.42B | 13.14B | 9 |
FQ3 2027 (Sep 2027) | 11.71B | -- | 11.55B | 11.91B | 4 |
FQ2 2027 (Jun 2027) | 11.51B | -- | 11.35B | 11.71B | 6 |
FQ1 2027 (Mar 2027) | 11.37B | -- | 11.22B | 11.57B | 4 |
FQ4 2026 (Oct 2026) | 11.51B | -- | 11.39B | 11.64B | 8 |
FQ3 2026 (Jul 2026) | 11.22B | -- | 11.1B | 11.35B | 5 |
FQ2 2026 (Jun 2026) | 11.31B | 8.46 | 11.19B | 11.5B | 10 |
FQ1 2026 (Mar 2026) | 11.03B | 14.14 | 10.91B | 11.21B | 10 |
FQ4 2025 (Oct 2025) | 10.75B | 0.64 | 10.64B | 10.88B | 6 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 6.665 | 8.17 | 1.505 | 18.42% |
FQ1 2025 (Mar 2025) | 3.33 | 3.33 | 100% | |
FQ4 2024 (Dec 2024) | 8.66 | 8.66 | 100% | |
FQ3 2024 (Sep 2024) | 6.96 | 6.96 | 100% | |
FQ2 2024 (Jun 2024) | 6.37 | 6.37 | 100% | |
FQ1 2024 (Mar 2024) | 6.34 | 6.34 | 100% | |
FQ4 2023 (Dec 2023) | 0 | 0 | NAN% | |
FQ3 2023 (Sep 2023) | 6.2 | 6.2 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $10.53B | $10.35B | $-180.74M | -1.75% |
FQ1 2025 (Mar 2025) | $0B | $9.47B | $9468M | 100% |
FQ4 2024 (Dec 2024) | $0B | $10.69B | $10686M | 100% |
FQ3 2024 (Sep 2024) | $0B | $10B | $9996M | 100% |
FQ2 2024 (Jun 2024) | $0B | $10.22B | $10218M | 100% |
FQ1 2024 (Mar 2024) | $0B | $10.13B | $10133M | 100% |
FQ4 2023 (Dec 2023) | $0B | $10.64B | $10638M | 100% |
FQ3 2023 (Sep 2023) | $0B | $9.78B | $9775M | 100% |